Roche Ends 2015 On Brighter Emerging Markets Note

Despite caution over emerging markets turmoil and a possible slowdown at the time of its third quarter results, in the end 2015 turned out well for Roche, with its pharma sales in key market China regaining momentum on the back of product expansions and oncology access schemes.